Immuneering IMRX
NASDAQ IMRX
$3.76 +0.11 (+2.88%)
As of: Nov 10, 2026 · 1:32 PM EST

Immuneering (IMRX) Receivables - Net (2020 - 2023)

Updated

Analysis

Immuneering (IMRX) Receivables - Net (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Immuneering 246.36 Mn -378.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 1,046.00
Dec 31, 2022 12,417.00
Sep 30, 2022 70,180.00
Jun 30, 2022 178,425.00
Mar 31, 2022 279,614.00
Dec 31, 2021 246,040.00
Sep 30, 2021 471,375.00
Jun 30, 2021 495,105.00
Dec 31, 2020 500,110.00
API Access

Immuneering Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=IMRX&period=max&api_key=YOUR_API_KEY